Changing the Perspective on Cardiac Amyloidosis: From Missed and Undiagnosed, to Common and Treatable

Jan 24, 2019 ‐ Jan 24, 2019


Author(s)/Faculty: Martha Grogan, MD; Mathew S. Maurer, MD ; Daniel Judge, MD, FHFSA; Mazen A. Hanna, MD; Jose Nativi-Nicolau, MD, MSCI; Ronald M. Witteles, MD
Source: Healio Education Lab - Cardiology
Type: LectureArticles/Items: 7
Release Date: 1/4/2019Expiration Date: 1/4/2020
Credit Type: CME / CNENumber of Credits: 2
Cost: FreeProvider: HFSA
Cardiac Amyloidosis is a rare systemic disorder characterized by proteins that possess abnormal conformational features leading them to aggregate and infiltrate tissues in the form of amyloid fibrils resulting in damage to the heart and Heart Failure. Non-specific presenting symptoms and failure to recognize early signs of amyloid heart disease often lead to delay in diagnosis of Cardiac Amyloidosis. Timely diagnosis is critical to managing the disease and preventing mortality. Moreover physicians must maintain a high level of suspicion in order to make a timely diagnosis. This program will examine Cardiac Amyloidosis as a whole; while discussing patient identification, along with current and emerging treatment options.

Click here to be redirected to access this course!

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content